Alnylam Terminates ssRNAi Collaboration with Isis

Alnylam said it had decided to exercise its right to terminate the ssRNAi collaboration, thereby returning all licenses to ssiRNAi technology back to Isis and eliminating its requirement to pay research funding.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.